Log in to save to my catalogue

Hyperbaric oxygen therapy suppresses hypoxia and reoxygenation injury to retinal pigment epithelial...

Hyperbaric oxygen therapy suppresses hypoxia and reoxygenation injury to retinal pigment epithelial...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10568664

Hyperbaric oxygen therapy suppresses hypoxia and reoxygenation injury to retinal pigment epithelial cells through activating peroxisome proliferator activator receptor‐alpha signalling

About this item

Full title

Hyperbaric oxygen therapy suppresses hypoxia and reoxygenation injury to retinal pigment epithelial cells through activating peroxisome proliferator activator receptor‐alpha signalling

Publisher

Chichester: John Wiley & Sons, Inc

Journal title

Journal of cellular and molecular medicine, 2023-10, Vol.27 (20), p.3189-3201

Language

English

Formats

Publication information

Publisher

Chichester: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Retinal ischemia followed by reperfusion (IR) is a common cause of many ocular disorders, such as age‐related macular degeneration (AMD), which leads to blindness in the elderly population, and proper therapies remain unavailable. Retinal pigment epithelial (RPE) cell death is a hallmark of AMD. Hyperbaric oxygen (HBO) therapy can improve IR tissue...

Alternative Titles

Full title

Hyperbaric oxygen therapy suppresses hypoxia and reoxygenation injury to retinal pigment epithelial cells through activating peroxisome proliferator activator receptor‐alpha signalling

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10568664

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10568664

Other Identifiers

ISSN

1582-1838

E-ISSN

1582-4934

DOI

10.1111/jcmm.17963

How to access this item